Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
MAZE THERAPEUTICS, INC. Reports Q1 2026 Financial Results
2026-05-12
SEC Filing 10-Q
(0001193125-26-219430)
Please check the link below for details.
Ticker mentioned:
MAZE
Source:
Original SEC Document β